Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, December 13, 2017
[ 12:00 AM ] - United States, WOPRAI
Tue, December 12, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, December 11, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Biren Amin Upgraded (BLUE) to Strong Buy on, Dec 11th, 2017
Biren Amin of Jefferies, Upgraded "bluebird bio, Inc." (BLUE) to Strong Buy on, Dec 11th, 2017.
Biren has made no other calls on BLUE in the last 4 months.
There are 7 other peers that have a rating on BLUE. Out of the 7 peers that are also analyzing BLUE, 2 agree with Biren's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, November 6th, 2017
- Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, November 3rd, 2017
These are the ratings of the 5 analyists that currently disagree with Biren
- John Newman of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $202 on, Tuesday, December 5th, 2017
- Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $200 on, Thursday, November 30th, 2017
- Dane Leone of "BTIG" Upgraded from Hold to Strong Buy on, Thursday, November 2nd, 2017
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $162 on, Thursday, November 2nd, 2017
- Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $162 on, Monday, October 30th, 2017
